The two antibiotic regimens were equally effective in a head-to-head one-year trial.
For treatment of spontaneous bacterial peritonitis (SBP) as a complication of ascites due to cirrhosis, the current standard of practice is to start daily antibiotics after the first episode of SBP to prevent recurrence. Although once-weekly ciprofloxacin has been shown to be effective in preventing recurrent SBP, no head-to-head comparison has been performed with daily antibiotics administration.
In an open-label, randomized, controlled trial, 124 patients with cirrhosis with ascites and history of previous SBP or presence of ascitic protein ≤1.5 g/dL were randomized to receive daily norfloxacin (400 mg) or weekly ciprofloxacin (750 mg) for 12 months. The primary endpoint was prevention of SBP (defined as the presence of ascitic polymorphon…
Reviewing Author
DisclosuresNothing to disclose
DisclosuresNothing to disclose